BioNTech reiterates presence in Africa; WuXi eyes first Chinese vaccine plant; Chinese drugmaker blocks FDA checks
Welcome to Endpoints’ manufacturing news briefs, where we bring you essential news on new builds, collaborations, recalls, and more.
This week, we look into WuXi …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.